These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17239009

  • 1. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, Antalffy BA, Blaney SM, Lau CC.
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H, Lu C, Mabuchi H, Tanigawa N.
    Cancer Lett; 2004 Dec 28; 216(2):147-55. PubMed ID: 15533590
    [Abstract] [Full Text] [Related]

  • 3. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
    Taubert H, Kappler M, Bache M, Bartel F, Köhler T, Lautenschläger C, Blümke K, Würl P, Schmidt H, Meye A, Hauptmann S.
    Oncogene; 2005 Aug 04; 24(33):5258-61. PubMed ID: 15856009
    [Abstract] [Full Text] [Related]

  • 4. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K, Yamamoto T, Yamada Y, Miyatake S, Nakagawa T, Tanigawa N.
    Oncol Rep; 2005 May 04; 13(5):891-7. PubMed ID: 15809755
    [Abstract] [Full Text] [Related]

  • 5. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.
    Urol J; 2009 May 04; 6(2):101-8. PubMed ID: 19472128
    [Abstract] [Full Text] [Related]

  • 6. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N.
    Lung Cancer; 2004 Dec 04; 46(3):299-304. PubMed ID: 15541814
    [Abstract] [Full Text] [Related]

  • 7. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S.
    Int J Oncol; 2005 Oct 04; 27(4):1151-7. PubMed ID: 16142334
    [Abstract] [Full Text] [Related]

  • 8. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
    Krieg A, Mahotka C, Krieg T, Grabsch H, Müller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD.
    Br J Cancer; 2002 Mar 04; 86(5):737-43. PubMed ID: 11875736
    [Abstract] [Full Text] [Related]

  • 9. Inhibitors of apoptosis proteins in human cervical cancer.
    Espinosa M, Cantú D, Herrera N, Lopez CM, De la Garza JG, Maldonado V, Melendez-Zajgla J.
    BMC Cancer; 2006 Feb 27; 6():45. PubMed ID: 16504151
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y, Yamaguchi S, Hasegawa M, Nemoto T, Inoue M, Suzuki K, Hirokawa K, Kitagawa M.
    Leuk Res; 2004 May 27; 28(5):487-94. PubMed ID: 15068902
    [Abstract] [Full Text] [Related]

  • 11. Survivin is a negative prognostic marker in medulloblastoma.
    Pizem J, Cört A, Zadravec-Zaletel L, Popovic M.
    Neuropathol Appl Neurobiol; 2005 Aug 27; 31(4):422-8. PubMed ID: 16008826
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y, Mowla SJ, Ziaee SA.
    Cancer Detect Prev; 2009 Aug 27; 32(4):308-13. PubMed ID: 19186007
    [Abstract] [Full Text] [Related]

  • 13. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
    Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K.
    Urology; 2008 Dec 27; 72(6):1229-33. PubMed ID: 18336887
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells.
    Moriai R, Asanuma K, Kobayashi D, Yajima T, Yagihashi A, Yamada M, Watanabe N.
    Anticancer Res; 2001 Dec 27; 21(1B):595-600. PubMed ID: 11299811
    [Abstract] [Full Text] [Related]

  • 15. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
    Tröger A, Siepermann M, Mahotka C, Wethkamp N, Bülle H, Laws HJ, Escherich G, Janka-Schaub G, Göbel U, Dilloo D.
    Klin Padiatr; 2007 Dec 27; 219(3):127-33. PubMed ID: 17525905
    [Abstract] [Full Text] [Related]

  • 16. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
    Bodey B, Bodey V, Siegel SE, Kaiser HE.
    In Vivo; 2004 Dec 27; 18(6):713-8. PubMed ID: 15646811
    [Abstract] [Full Text] [Related]

  • 17. Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types.
    Salsano E, Pollo B, Eoli M, Giordana MT, Finocchiaro G.
    Neurosci Lett; 2004 Nov 11; 370(2-3):180-5. PubMed ID: 15488319
    [Abstract] [Full Text] [Related]

  • 18. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
    Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD.
    Cancer Res; 1999 Dec 15; 59(24):6097-102. PubMed ID: 10626797
    [Abstract] [Full Text] [Related]

  • 19. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
    Chen YK, Hsue SS, Lin LM.
    Arch Oral Biol; 2005 Jun 15; 50(6):593-8. PubMed ID: 15848153
    [Abstract] [Full Text] [Related]

  • 20. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, Kannan S, Pathak KA, Choudhary M, Teni TR.
    J Pathol; 2009 Feb 15; 217(3):398-407. PubMed ID: 19009587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.